| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.20e-08 | 37 | 111 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.61e-06 | 18 | 111 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.67e-05 | 28 | 111 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.40e-05 | 70 | 111 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.12e-05 | 118 | 111 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 MYH9 DNAH2 INO80 KIFC2 MDN1 DNAH17 SHPRH HLTF DNAH9 DDX28 | 6.23e-04 | 614 | 111 | 11 | GO:0140657 |
| GeneOntologyBiologicalProcess | microtubule-based process | DNHD1 MYH9 SPEM3 DNAH2 CLASP2 FYCO1 INO80 TUBGCP5 KIFC2 TBC1D32 DST INSC DNAH17 ESPL1 DNAH9 ARHGAP21 HTT BBOF1 | 1.53e-05 | 1058 | 112 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | establishment of spindle localization | 2.18e-05 | 62 | 112 | 5 | GO:0051293 | |
| GeneOntologyBiologicalProcess | spindle localization | 3.19e-05 | 67 | 112 | 5 | GO:0051653 | |
| GeneOntologyBiologicalProcess | Golgi organization | 3.71e-05 | 168 | 112 | 7 | GO:0007030 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYH9 CLASP2 FYCO1 TRAPPC8 MDN1 PPP6C INSC IRAG2 ESPL1 ARHGAP21 UNC13A HTT | 4.19e-05 | 546 | 112 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | microtubule-based movement | DNHD1 SPEM3 DNAH2 FYCO1 KIFC2 DST DNAH17 DNAH9 ARHGAP21 HTT BBOF1 | 7.78e-05 | 493 | 112 | 11 | GO:0007018 |
| GeneOntologyBiologicalProcess | sexual reproduction | SOX9 DNHD1 MYH9 SPEM3 PAQR5 CLASP2 VPS54 NR6A1 TEX15 SOX8 TUBGCP5 AXDND1 KMT2D BRDT IRAG2 ESPL1 VPS13B HTT BBOF1 | 7.86e-05 | 1312 | 112 | 19 | GO:0019953 |
| GeneOntologyBiologicalProcess | beta-catenin-TCF complex assembly | 8.74e-05 | 3 | 112 | 2 | GO:1904837 | |
| GeneOntologyBiologicalProcess | renal vesicle induction | 8.74e-05 | 3 | 112 | 2 | GO:0072034 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 8.75e-05 | 334 | 112 | 9 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 8.75e-05 | 334 | 112 | 9 | GO:0001894 | |
| GeneOntologyBiologicalProcess | establishment of mitotic spindle localization | 9.46e-05 | 44 | 112 | 4 | GO:0040001 | |
| GeneOntologyBiologicalProcess | organelle localization | MYH9 CLASP2 FYCO1 TRAPPC8 MDN1 PPP6C INSC IRAG2 ESPL1 BRAT1 ARHGAP21 UNC13A HTT | 1.15e-04 | 703 | 112 | 13 | GO:0051640 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MYH9 DNAH2 CLASP2 INO80 TUBGCP5 KIFC2 TBC1D32 DST INSC DNAH17 ESPL1 HTT BBOF1 | 1.45e-04 | 720 | 112 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | homeostasis of number of cells within a tissue | 1.69e-04 | 51 | 112 | 4 | GO:0048873 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule formation | 1.74e-04 | 4 | 112 | 2 | GO:0072289 | |
| GeneOntologyBiologicalProcess | astrocyte fate commitment | 1.74e-04 | 4 | 112 | 2 | GO:0060018 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 2.23e-04 | 22 | 112 | 3 | GO:0015810 | |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | 2.24e-04 | 224 | 112 | 7 | GO:0051650 | |
| GeneOntologyCellularComponent | cytoplasmic region | DNHD1 DNAH2 CLASP2 SPTBN5 DST INSC DNAH17 DNAH9 UNC13A HTT BBOF1 | 4.88e-06 | 360 | 115 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.01e-05 | 25 | 115 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | cell cortex region | 1.09e-04 | 45 | 115 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | dynein complex | 2.22e-04 | 54 | 115 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.68e-04 | 161 | 115 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.72e-04 | 317 | 115 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 7.39e-04 | 129 | 115 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | axoneme | 1.01e-03 | 207 | 115 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.03e-03 | 208 | 115 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | cell cortex | 1.04e-03 | 371 | 115 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | spectrin | 1.05e-03 | 9 | 115 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | apical cortex | 1.31e-03 | 10 | 115 | 2 | GO:0045179 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.31e-03 | 10 | 115 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.91e-03 | 12 | 115 | 2 | GO:0036157 | |
| Domain | Sox_N | 1.99e-07 | 3 | 110 | 3 | IPR022151 | |
| Domain | Sox_N | 1.99e-07 | 3 | 110 | 3 | PF12444 | |
| Domain | Spectrin | 9.25e-06 | 23 | 110 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 2.41e-05 | 29 | 110 | 4 | IPR002017 | |
| Domain | DUF3402 | 3.44e-05 | 2 | 110 | 2 | SM01293 | |
| Domain | N1221 | 3.44e-05 | 2 | 110 | 2 | SM01292 | |
| Domain | DUF3402 | 3.44e-05 | 2 | 110 | 2 | PF11882 | |
| Domain | N1221 | 3.44e-05 | 2 | 110 | 2 | PF07923 | |
| Domain | DUF3402 | 3.44e-05 | 2 | 110 | 2 | IPR021819 | |
| Domain | N1221 | 3.44e-05 | 2 | 110 | 2 | IPR012486 | |
| Domain | Dynein_HC_stalk | 6.90e-05 | 14 | 110 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.90e-05 | 14 | 110 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.90e-05 | 14 | 110 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.90e-05 | 14 | 110 | 3 | IPR011704 | |
| Domain | MT | 6.90e-05 | 14 | 110 | 3 | PF12777 | |
| Domain | AAA_5 | 6.90e-05 | 14 | 110 | 3 | PF07728 | |
| Domain | DHC_fam | 8.59e-05 | 15 | 110 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 8.59e-05 | 15 | 110 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.59e-05 | 15 | 110 | 3 | IPR004273 | |
| Domain | GPCR_2_EMR1-like_rcpt | 1.03e-04 | 3 | 110 | 2 | IPR001740 | |
| Domain | ARM-type_fold | 1.79e-04 | 339 | 110 | 9 | IPR016024 | |
| Domain | HEAT | 1.82e-04 | 48 | 110 | 4 | PF02985 | |
| Domain | HMG_box | 2.67e-04 | 53 | 110 | 4 | PF00505 | |
| Domain | HMG | 2.87e-04 | 54 | 110 | 4 | SM00398 | |
| Domain | - | 3.08e-04 | 55 | 110 | 4 | 1.10.30.10 | |
| Domain | ACTININ_2 | 3.23e-04 | 23 | 110 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.23e-04 | 23 | 110 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.23e-04 | 23 | 110 | 3 | IPR001589 | |
| Domain | FYrich_C | 3.40e-04 | 5 | 110 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.40e-04 | 5 | 110 | 2 | IPR003888 | |
| Domain | FYRC | 3.40e-04 | 5 | 110 | 2 | SM00542 | |
| Domain | FYRN | 3.40e-04 | 5 | 110 | 2 | SM00541 | |
| Domain | FYRN | 3.40e-04 | 5 | 110 | 2 | PF05964 | |
| Domain | FYRC | 3.40e-04 | 5 | 110 | 2 | PF05965 | |
| Domain | FYRC | 3.40e-04 | 5 | 110 | 2 | PS51543 | |
| Domain | FYRN | 3.40e-04 | 5 | 110 | 2 | PS51542 | |
| Domain | HEAT | 3.78e-04 | 58 | 110 | 4 | IPR000357 | |
| Domain | HMG_box_dom | 5.85e-04 | 65 | 110 | 4 | IPR009071 | |
| Domain | HEAT_REPEAT | 7.75e-04 | 70 | 110 | 4 | PS50077 | |
| Domain | SNF2_N | 8.71e-04 | 32 | 110 | 3 | IPR000330 | |
| Domain | SNF2_N | 8.71e-04 | 32 | 110 | 3 | PF00176 | |
| Domain | SPEC | 8.71e-04 | 32 | 110 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 8.71e-04 | 32 | 110 | 3 | IPR018159 | |
| Domain | DHC_N1 | 9.40e-04 | 8 | 110 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 9.40e-04 | 8 | 110 | 2 | IPR013594 | |
| Domain | GPS | 1.04e-03 | 34 | 110 | 3 | SM00303 | |
| Domain | GPS | 1.13e-03 | 35 | 110 | 3 | PF01825 | |
| Domain | PH_dom-spectrin-type | 1.20e-03 | 9 | 110 | 2 | IPR001605 | |
| Domain | GPS | 1.23e-03 | 36 | 110 | 3 | PS50221 | |
| Domain | GPS | 1.33e-03 | 37 | 110 | 3 | IPR000203 | |
| Domain | P-loop_NTPase | DNHD1 MYH9 DNAH2 PFKFB3 INO80 KIFC2 NLRC4 TRANK1 MDN1 SHPRH HLTF DNAH9 DDX28 | 1.44e-03 | 848 | 110 | 13 | IPR027417 |
| Domain | LRR_5 | 1.50e-03 | 10 | 110 | 2 | PF13306 | |
| Domain | LRR_5 | 1.50e-03 | 10 | 110 | 2 | IPR026906 | |
| Domain | - | 2.02e-03 | 222 | 110 | 6 | 1.25.10.10 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.99e-03 | 14 | 110 | 2 | IPR024317 | |
| Domain | AAA_8 | 2.99e-03 | 14 | 110 | 2 | PF12780 | |
| Domain | 7tm_2 | 3.19e-03 | 50 | 110 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.19e-03 | 50 | 110 | 3 | PS00650 | |
| Domain | Helicase_C | 3.69e-03 | 107 | 110 | 4 | PF00271 | |
| Domain | HELICc | 3.69e-03 | 107 | 110 | 4 | SM00490 | |
| Domain | Helicase_C | 3.82e-03 | 108 | 110 | 4 | IPR001650 | |
| Domain | Post-SET_dom | 3.91e-03 | 16 | 110 | 2 | IPR003616 | |
| Domain | PostSET | 3.91e-03 | 16 | 110 | 2 | SM00508 | |
| Domain | POST_SET | 3.91e-03 | 16 | 110 | 2 | PS50868 | |
| Domain | HELICASE_CTER | 3.94e-03 | 109 | 110 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.94e-03 | 109 | 110 | 4 | PS51192 | |
| Domain | DEXDc | 3.94e-03 | 109 | 110 | 4 | SM00487 | |
| Domain | HMG_BOX_2 | 3.96e-03 | 54 | 110 | 3 | PS50118 | |
| Domain | Helicase_ATP-bd | 4.07e-03 | 110 | 110 | 4 | IPR014001 | |
| Domain | - | DNHD1 DNAH2 PFKFB3 INO80 NLRC4 TRANK1 MDN1 SHPRH HLTF DNAH9 DDX28 | 4.52e-03 | 746 | 110 | 11 | 3.40.50.300 |
| Domain | ARM-like | 5.29e-03 | 270 | 110 | 6 | IPR011989 | |
| Domain | GPCR_2_secretin-like | 5.33e-03 | 60 | 110 | 3 | IPR000832 | |
| Domain | RUN | 5.51e-03 | 19 | 110 | 2 | PS50826 | |
| Domain | RUN | 5.51e-03 | 19 | 110 | 2 | PF02759 | |
| Domain | Run_dom | 5.51e-03 | 19 | 110 | 2 | IPR004012 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 5.58e-03 | 61 | 110 | 3 | PS50261 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 SEMA6B ACACA NTSR1 RPSA CLASP2 FYCO1 INO80 KIFC2 DIP2A URB1 KMT2D DST MDN1 ESPL1 BRAT1 ARHGAP21 HTT | 2.47e-08 | 1105 | 115 | 18 | 35748872 |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18512230 | ||
| Pubmed | The SOXE transcription factors-SOX8, SOX9 and SOX10-share a bi-partite transactivation mechanism. | 3.52e-08 | 3 | 115 | 3 | 31194875 | |
| Pubmed | RBBP7 ECT2L TFIP11 RPSA CLASP2 INO80 PLPP6 STRIP1 URB1 DST MDN1 INTS2 TADA2B DNAJC9 HLTF ASCC2 KMT2A UTP20 MED23 DDX28 | 9.84e-08 | 1497 | 115 | 20 | 31527615 | |
| Pubmed | SOXE group transcription factors regulates the expression of FoxG1 during inner ear development. | 1.41e-07 | 4 | 115 | 3 | 35878429 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LRRC8C MYH9 ACACA DNAH2 NUP205 DIP2A URB1 DST MDN1 AGL GZMH UTP20 TAS2R31 PLXNB3 | 1.59e-07 | 736 | 115 | 14 | 29676528 |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 15878625 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACA SPTBN1 TFIP11 CLASP2 DIP2A TRANK1 MDN1 SHPRH ASCC2 KMT2A ARHGAP21 | 8.50e-07 | 497 | 115 | 11 | 36774506 |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 19490914 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 31178125 | ||
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 1.34e-06 | 104 | 115 | 6 | 26167872 | |
| Pubmed | MYH9 NAA15 ACACA RBBP7 SPTBN1 RPSA NUP205 URB1 DST MDN1 KMT2A UTP20 | 1.84e-06 | 653 | 115 | 12 | 22586326 | |
| Pubmed | NAA15 ACACA RBBP7 FYCO1 TRAPPC8 NUP205 STK4 AGL RAB3GAP2 DZIP3 | 2.04e-06 | 437 | 115 | 10 | 20562859 | |
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 26546974 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYH9 RBBP7 DIPK1A SPTBN1 CYP20A1 PLD3 DIP2A MDN1 INTS2 BRDT PIK3CB DNAH17 IRAG2 LONRF3 MED23 PLXNB3 | 3.44e-06 | 1242 | 115 | 16 | 30973865 |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 3.44e-06 | 69 | 115 | 5 | 28481362 | |
| Pubmed | Med23 Regulates Sox9 Expression during Craniofacial Development. | 4.16e-06 | 10 | 115 | 3 | 33155500 | |
| Pubmed | Phenotypes of neural-crest-derived cells in vagal and sacral pathways. | 4.16e-06 | 10 | 115 | 3 | 16133146 | |
| Pubmed | 5.52e-06 | 288 | 115 | 8 | 23383273 | ||
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 19933217 | ||
| Pubmed | SoxE proteins are differentially required in mouse adrenal gland development. | 7.58e-06 | 12 | 115 | 3 | 18272785 | |
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 11071752 | ||
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 20871603 | ||
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 7590241 | ||
| Pubmed | DENND5B MYH9 ACACA RBBP7 CLASP2 VPS54 TUBGCP5 NUP205 INTS2 PIK3CB RAB3GAP2 TADA2B SF3A3 DNAJC9 KMT2A HTT | 7.90e-06 | 1327 | 115 | 16 | 32694731 | |
| Pubmed | MYH9 ACACA SPTBN1 DNAH2 KIFC2 NUP205 SHPRH IRAG2 SF3A3 HLTF MED23 ARHGAP21 | 7.94e-06 | 754 | 115 | 12 | 35906200 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | POGLUT3 MYH9 FYCO1 PLD3 STK4 URB1 MDN1 INTS2 DCAF10 ASCC2 UTP20 BRAT1 | 7.94e-06 | 754 | 115 | 12 | 33060197 |
| Pubmed | POGLUT3 NAA15 SPTBN1 TFIP11 CLASP2 TRAPPC8 PLD3 DIP2A URB1 MDN1 PPP6C RAB3GAP2 LRRC1 DNAJC9 ASCC2 ESPL1 VPS13B | 8.04e-06 | 1487 | 115 | 17 | 33957083 | |
| Pubmed | Seven new members of the Sox gene family expressed during mouse development. | 9.83e-06 | 13 | 115 | 3 | 8441686 | |
| Pubmed | Origin and possible roles of the Sox8 transcription factor gene during sexual development. | 1.08e-05 | 2 | 115 | 2 | 14689607 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33985544 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 39201442 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25629959 | ||
| Pubmed | Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo. | 1.08e-05 | 2 | 115 | 2 | 26711341 | |
| Pubmed | Expression of SOX9 and SOX10 in central neuroepithelial tumor. | 1.08e-05 | 2 | 115 | 2 | 16791471 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24423662 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23315995 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33597301 | ||
| Pubmed | Gene structure and transcript analysis of the human and mouse EGF-TM7 molecule, FIRE. | 1.08e-05 | 2 | 115 | 2 | 16753812 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12588993 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11564768 | ||
| Pubmed | Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. | 1.08e-05 | 2 | 115 | 2 | 15896776 | |
| Pubmed | Expression of connexin47 in oligodendrocytes is regulated by the Sox10 transcription factor. | 1.08e-05 | 2 | 115 | 2 | 16822525 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32192191 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22298706 | ||
| Pubmed | 1.25e-05 | 14 | 115 | 3 | 8921394 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.25e-05 | 14 | 115 | 3 | 18794798 | |
| Pubmed | 1.56e-05 | 15 | 115 | 3 | 15893981 | ||
| Pubmed | 1.56e-05 | 15 | 115 | 3 | 22837482 | ||
| Pubmed | 1.56e-05 | 15 | 115 | 3 | 20144603 | ||
| Pubmed | 1.56e-05 | 15 | 115 | 3 | 29361054 | ||
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 1.56e-05 | 15 | 115 | 3 | 30871468 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.99e-05 | 344 | 115 | 8 | 30333137 | |
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 2.32e-05 | 17 | 115 | 3 | 27241892 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYH9 RBBP7 TFIP11 INO80 URB1 KMT2D DST MDN1 INTS2 TADA2B SF3A3 DNAJC9 HLTF KMT2A UTP20 | 2.46e-05 | 1294 | 115 | 15 | 30804502 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYH9 ACACA RBBP7 TFIP11 RPSA NUP205 URB1 MDN1 SF3A3 DNAJC9 HLTF UTP20 BRAT1 | 2.47e-05 | 989 | 115 | 13 | 36424410 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH9 NAA15 ACACA RBBP7 SPTBN1 RPSA CLASP2 DST MDN1 PPP6C AGL RAB3GAP2 SF3A3 DNAJC9 | 2.73e-05 | 1149 | 115 | 14 | 35446349 |
| Pubmed | 2.77e-05 | 18 | 115 | 3 | 26864488 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NAA15 ACACA RBBP7 SPTBN1 CLASP2 STK4 DST MDN1 RAB3GAP2 KMT2A ARHGAP21 DOP1A | 2.94e-05 | 861 | 115 | 12 | 36931259 |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26467042 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26902498 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23932714 | ||
| Pubmed | The STRIPAK complex components FAM40A and FAM40B regulate endothelial cell contractility via ROCKs. | 3.24e-05 | 3 | 115 | 2 | 30509168 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 22782902 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 21269891 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23192982 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 31973093 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 12709506 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 12023293 | ||
| Pubmed | Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia. | 3.24e-05 | 3 | 115 | 2 | 30315824 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 22798246 | ||
| Pubmed | LRRC8C MYH9 NAA15 CYP20A1 RPSA CLASP2 FYCO1 NUP205 MDN1 INTS2 GZMH IRAG2 HLTF BRAT1 | 3.26e-05 | 1168 | 115 | 14 | 19946888 | |
| Pubmed | POGLUT3 TFIP11 CLASP2 PLD3 STRIP2 STRIP1 STK4 PPP6C RAB3GAP2 SF3A3 ESPL1 | 3.31e-05 | 733 | 115 | 11 | 34672954 | |
| Pubmed | 3.85e-05 | 20 | 115 | 3 | 21466799 | ||
| Pubmed | CHD7 regulates cardiovascular development through ATP-dependent and -independent activities. | 3.85e-05 | 20 | 115 | 3 | 33127760 | |
| Pubmed | Transcriptome profiling of mouse brain and lung under Dip2a regulation using RNA-sequencing. | 3.85e-05 | 20 | 115 | 3 | 31291246 | |
| Pubmed | Sox9 is required for invagination of the otic placode in mice. | 3.85e-05 | 20 | 115 | 3 | 18377888 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 NAA15 ACACA SPTBN1 TFIP11 RPSA NUP205 STK4 URB1 DST MDN1 PPP6C SF3A3 HLTF UTP20 | 4.09e-05 | 1353 | 115 | 15 | 29467282 |
| Pubmed | The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas. | 4.48e-05 | 21 | 115 | 3 | 16306355 | |
| Pubmed | Testicular differentiation occurs in absence of R-spondin1 and Sox9 in mouse sex reversals. | 4.48e-05 | 21 | 115 | 3 | 23300469 | |
| Pubmed | Expression of Sox transcription factors in the developing mouse pancreas. | 4.48e-05 | 21 | 115 | 3 | 12815626 | |
| Pubmed | 5.18e-05 | 22 | 115 | 3 | 30951662 | ||
| Pubmed | 5.18e-05 | 22 | 115 | 3 | 17084361 | ||
| Pubmed | 5.18e-05 | 22 | 115 | 3 | 25888505 | ||
| Pubmed | The Sox9 transcription factor determines glial fate choice in the developing spinal cord. | 5.94e-05 | 23 | 115 | 3 | 12842915 | |
| Pubmed | DIPK1A SPTBN1 TFIP11 CLASP2 INO80 KIFC2 URB1 PPP6C INTS2 DZIP3 ESPL1 ARHGAP21 VPS13B | 6.32e-05 | 1084 | 115 | 13 | 11544199 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 22863532 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 37722486 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 8791525 | ||
| Pubmed | Mst1 directs Myosin IIa partitioning of low and higher affinity integrins during T cell migration. | 6.48e-05 | 4 | 115 | 2 | 25133611 | |
| Pubmed | SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells. | 6.48e-05 | 4 | 115 | 2 | 18923447 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 20154145 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 10087204 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 6.48e-05 | 4 | 115 | 2 | 23129768 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 24081332 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 14637006 | ||
| Pubmed | Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins. | 6.48e-05 | 4 | 115 | 2 | 11875113 | |
| Pubmed | 6.78e-05 | 24 | 115 | 3 | 34233187 | ||
| Pubmed | 6.78e-05 | 24 | 115 | 3 | 17537790 | ||
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 7.68e-05 | 25 | 115 | 3 | 38687251 | |
| Interaction | GPR17 interactions | 3.76e-06 | 283 | 111 | 10 | int:GPR17 | |
| Interaction | GPR182 interactions | NTSR1 ARFGEF1 TUBGCP5 PLPP6 NUP205 URB1 MDN1 KCNN4 UTP20 MED23 BRAT1 HTT | 7.94e-06 | 455 | 111 | 12 | int:GPR182 |
| Interaction | KDM1A interactions | MYH9 ACACA RBBP7 TFIP11 FYCO1 SOX8 BMP3 KMT2D DST INTS2 RAB3GAP2 SF3A3 DZIP3 ASCC2 MED23 ARHGAP21 HTT | 1.50e-05 | 941 | 111 | 17 | int:KDM1A |
| Cytoband | 19q13.2 | 6.12e-05 | 164 | 115 | 5 | 19q13.2 | |
| GeneFamily | Dyneins, axonemal | 3.96e-05 | 17 | 72 | 3 | 536 | |
| GeneFamily | SRY-boxes | 5.61e-05 | 19 | 72 | 3 | 757 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 1.55e-04 | 5 | 72 | 2 | 915 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.24e-04 | 7 | 72 | 2 | 1113 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.40e-04 | 11 | 72 | 2 | 1315 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 2.84e-03 | 20 | 72 | 2 | 1371 | |
| Coexpression | GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN | 2.75e-06 | 200 | 114 | 8 | M3659 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN | 1.88e-05 | 188 | 114 | 7 | M40862 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP | 2.71e-05 | 199 | 114 | 7 | M9369 | |
| Coexpression | GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN | 2.71e-05 | 199 | 114 | 7 | M8356 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP | 2.71e-05 | 199 | 114 | 7 | M4271 | |
| Coexpression | GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP | 2.80e-05 | 200 | 114 | 7 | M4827 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN | 2.80e-05 | 200 | 114 | 7 | M8651 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.17e-07 | 195 | 114 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.68e-07 | 197 | 114 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.48e-06 | 186 | 114 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 192 | 114 | 6 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 193 | 114 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 194 | 114 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.11e-05 | 195 | 114 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.14e-05 | 196 | 114 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-05 | 196 | 114 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 114 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 114 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 114 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.21e-05 | 198 | 114 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 1.28e-05 | 117 | 114 | 5 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.93e-05 | 139 | 114 | 5 | bb2b020dda32ddc60ec9952de5b01acee60b5b59 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-05 | 150 | 114 | 5 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 4.79e-05 | 154 | 114 | 5 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 155 | 114 | 5 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 164 | 114 | 5 | df9fe446c1a43100048e11c01bf009bec3414dcf | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 164 | 114 | 5 | 67c636a2cc32e56c6186dc7e779cc19af04639d2 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 164 | 114 | 5 | eae6d440877b292ad18dc4bd02802dda5b2f9c60 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 7.03e-05 | 167 | 114 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 167 | 114 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-05 | 169 | 114 | 5 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 7.64e-05 | 170 | 114 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-05 | 171 | 114 | 5 | 4c36d0bf5fa3ddc2144f60769bb288ca4e4e20bc | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-05 | 171 | 114 | 5 | c5c1d23b4040a78991512bfcbe046c51f202d2cf | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.76e-05 | 175 | 114 | 5 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 178 | 114 | 5 | 445fb243d738a34794d66f34b92dde1f3ea6738e | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 178 | 114 | 5 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 1.08e-04 | 183 | 114 | 5 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.08e-04 | 183 | 114 | 5 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-04 | 185 | 114 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-04 | 185 | 114 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 185 | 114 | 5 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-04 | 186 | 114 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.20e-04 | 187 | 114 | 5 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 188 | 114 | 5 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.26e-04 | 189 | 114 | 5 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 1.29e-04 | 190 | 114 | 5 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.29e-04 | 190 | 114 | 5 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | 9d53b42cdb537b30233cdfdc08052c8b13a1113f | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.35e-04 | 192 | 114 | 5 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | 042391162df2e3d0027688dd14163c4c6821afe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | 71b0bfee0461ff64cef35881db3959c517e9731b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 193 | 114 | 5 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-04 | 193 | 114 | 5 | 5c5543e7c83ecea44d23521246592c0301044173 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 193 | 114 | 5 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-04 | 193 | 114 | 5 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-04 | 194 | 114 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 195 | 114 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | proximal-Epithelial-Serous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-04 | 195 | 114 | 5 | 06b73abc1f32543f2a51db52dc6424a2a398fe0f | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-04 | 195 | 114 | 5 | 0b0615553b9a1b60d666d074ce4260919e2d5642 | |
| ToppCell | proximal-Epithelial-Serous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-04 | 195 | 114 | 5 | cb62f04f0e45bfb36eed2e7a3fc54d6d390b2ed1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 195 | 114 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 195 | 114 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.45e-04 | 195 | 114 | 5 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | proximal-3-Epithelial-Serous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-04 | 195 | 114 | 5 | 24a6a566143b04e37ad002e4c55037a0460ac2ef | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.45e-04 | 195 | 114 | 5 | dabf667875ed48fdce4f803f5ead39c71a6df42b | |
| ToppCell | distal-Hematologic-OLR1+_Classical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.49e-04 | 196 | 114 | 5 | 80fc5b9e04ead0b38304dccbe39f66575e2bf203 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 196 | 114 | 5 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-04 | 196 | 114 | 5 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | distal-Hematologic-OLR1+_Classical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.49e-04 | 196 | 114 | 5 | 3f57216dbc9ef28fca09bbb8805f7c15b03b99e8 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 196 | 114 | 5 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.49e-04 | 196 | 114 | 5 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 196 | 114 | 5 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 196 | 114 | 5 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.49e-04 | 196 | 114 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 196 | 114 | 5 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.53e-04 | 197 | 114 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.53e-04 | 197 | 114 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-04 | 197 | 114 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 197 | 114 | 5 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-04 | 197 | 114 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.56e-04 | 198 | 114 | 5 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 198 | 114 | 5 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | distal-2-Hematologic-OLR1+_Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 114 | 5 | 43179d92e45b14f6f3d63949a9d88c2c7531f7d1 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 198 | 114 | 5 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | medial-2-Hematologic-OLR1+_Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 114 | 5 | d0a63cb48deecfdb8902c9229e457b7678aff178 | |
| ToppCell | medial-Hematologic-OLR1+_Classical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 114 | 5 | 74f79fd3b173c236e79b8b8f59a3b7c02ea082c6 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class | 1.56e-04 | 198 | 114 | 5 | 90f3b227cbc61c268d6d94bc9945a08d83d2d3d5 | |
| ToppCell | medial-Hematologic-OLR1+_Classical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 114 | 5 | 3f21354eb3e5f0949aec21dc2a8940e70464ecc7 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.60e-04 | 199 | 114 | 5 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.64e-04 | 200 | 114 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 1.64e-04 | 200 | 114 | 5 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.64e-04 | 200 | 114 | 5 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-04 | 200 | 114 | 5 | a4c41509ca936e137230a6ae548c90f18a566d12 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 4.29e-04 | 39 | 111 | 3 | EFO_0008298 | |
| Disease | Malignant neoplasm of breast | MYH9 XDH TRAPPC8 ATP6AP1L KMT2D PIK3CB UTP20 LONRF3 DNAH9 VPS13B PLEKHA8 DOP1A | 7.32e-04 | 1074 | 111 | 12 | C0006142 |
| Disease | pneumonia, COVID-19 | 8.91e-04 | 113 | 111 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0800573 | |
| Disease | optic disc size measurement | 1.09e-03 | 205 | 111 | 5 | EFO_0004832 | |
| Disease | benign prostatic hyperplasia | 1.24e-03 | 14 | 111 | 2 | EFO_0000284 | |
| Disease | response to calcium channel blocker | 1.24e-03 | 56 | 111 | 3 | EFO_0007767 | |
| Disease | white matter integrity | 1.50e-03 | 130 | 111 | 4 | EFO_0004641 | |
| Disease | red blood cell density measurement | POGLUT3 PSG1 SPTBN1 DNAH2 INO80 NUP205 DST KCNN4 TVP23A VPS13B | 1.81e-03 | 880 | 111 | 10 | EFO_0007978 |
| Disease | congenital heart disease (implicated_via_orthology) | 2.27e-03 | 69 | 111 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.30e-03 | 19 | 111 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | etiocholanolone glucuronide measurement | 2.30e-03 | 19 | 111 | 2 | EFO_0800362 | |
| Disease | respiratory symptom measurement, COVID-19 | 2.77e-03 | 74 | 111 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | mean reticulocyte volume | 3.25e-03 | 799 | 111 | 9 | EFO_0010701 | |
| Disease | frailty measurement | 3.37e-03 | 23 | 111 | 2 | EFO_0009885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIKNLDFWSKLITLI | 1041 | Q9UPW8 | |
| LTKLLESENRWKLVI | 381 | Q5W0A0 | |
| LSLRLLSKDKQVEKW | 191 | P16452 | |
| LWRKKLHLTLSANLE | 526 | P16452 | |
| VLKKAFQATLRWLLS | 466 | Q6PJG6 | |
| SWLSKDITQLLRKAK | 196 | P12645 | |
| LLLCLKISDKQTEWI | 931 | Q96NH3 | |
| KSKLWLLKDRDLARQ | 901 | Q58F21 | |
| RQLLFNKLSALSSWK | 846 | Q5T601 | |
| AWTNLLLLFLTKVLK | 1776 | Q9Y6D6 | |
| KRRLEDSKLLGDLWQ | 296 | Q9H1I8 | |
| LLQLERKAKWTTAVR | 111 | P20718 | |
| WILRSKLSSLNKEVS | 361 | Q86SQ3 | |
| SRLWKLRVLQAELKI | 1501 | Q13085 | |
| WASLLILLKDSIQLS | 1921 | Q5JWR5 | |
| DKFLWLSVLRNAIKS | 886 | Q008S8 | |
| KWLASLEKCLRLALV | 1446 | Q96M86 | |
| ALLELWDKVAGRLLL | 241 | Q9P1Z9 | |
| LTWEQKEKVLRLLFA | 441 | Q8ND07 | |
| GKDLSLLHSILRTWK | 381 | Q6DHV5 | |
| LLHSILRTWKQIKSL | 386 | Q6DHV5 | |
| ALKSSSSVRWKILLQ | 656 | Q9ULG1 | |
| LKALIQSRRGKTWTL | 146 | Q92621 | |
| AILLDKTLRKEWLLA | 271 | Q9NXK6 | |
| SLLLSVWLSKEKDIL | 771 | Q9H2M9 | |
| NWKRRALKEISLFLI | 521 | Q7RTS5 | |
| AAEKKARWVLLVLIL | 31 | Q8IV08 | |
| TLKKSLLQAWGLILR | 2856 | Q9NU22 | |
| KRLLEQEKSLAGWAL | 16 | O15554 | |
| KLGLKNWRLTDTEIR | 911 | Q9NPP4 | |
| KKFISAIWLASALLA | 186 | P30989 | |
| ILKQLSLLDSRWEAL | 5471 | Q03001 | |
| LIELLRDKDALWQKS | 1141 | Q9BQS8 | |
| KTNSLLLRFWVNALK | 1751 | Q9ULL4 | |
| LKDLRVWTSQLKSTI | 291 | Q16875 | |
| DTTIALWDLRKLNTK | 231 | Q5QP82 | |
| SQSWAQDKKLILRLL | 61 | Q9H0H0 | |
| RTQLWALTFKLVRKI | 111 | Q9ULK4 | |
| LWKALKSRLISLEQL | 266 | Q9NUL7 | |
| IRETLWLLSGVKKLF | 271 | Q96RT8 | |
| FRWLVLRINKALDKT | 426 | P35579 | |
| ATEALLWLKRGLKFL | 401 | Q96JA3 | |
| VNRKLSDVWKELSLL | 101 | Q8NB16 | |
| FNSIWKKVSDILLRL | 526 | Q86Y13 | |
| ALKWDKDNLQILRDL | 106 | Q9BXJ9 | |
| GLWKLKSLQSLDLSF | 166 | Q68CR7 | |
| SLTALKLKALWLSDN | 376 | Q9BTT6 | |
| TVALWDLRNLKLKLH | 296 | Q16576 | |
| KFELRKPLVLWSLTL | 56 | Q9H5J4 | |
| CLDQALALWKELLTK | 746 | Q14674 | |
| DKWKRLSRQIADIIL | 1601 | P42858 | |
| LAKLKALEDRVWELL | 71 | Q6ZP82 | |
| EELSLLRLAWQLKAT | 661 | Q6ZP82 | |
| TKLTQNVDLLALLKW | 601 | Q8IZD9 | |
| EKAAKWILAAVALLL | 4446 | Q9UFH2 | |
| SLREWKLFQALKLNL | 191 | P32246 | |
| TEDLALLQKLTQKWR | 446 | Q5T1B0 | |
| LDILLSWIKKLLESS | 156 | Q9NPH9 | |
| ARAWIRLSLEKKLLS | 866 | Q6ZUT9 | |
| WRLLFKKISLEDIQA | 101 | Q8WXX5 | |
| ALKSWKGLIQALLDA | 61 | Q9BPY3 | |
| LQLLLKRGWVISTEL | 121 | Q1MX18 | |
| LKSSIRKANKALWLS | 486 | Q12912 | |
| EWRLALEKELQISLK | 1631 | Q03164 | |
| LLNIIKRWSLLFKQH | 1096 | Q9NYC9 | |
| NSLKDLWSLLSFLKL | 591 | Q14527 | |
| LLLKLSEELLDKWLS | 141 | Q6UW02 | |
| WSRSLKLAYTLLNKL | 371 | Q14689 | |
| EHSLILNNLKTLLWK | 406 | Q5T7M9 | |
| LRLNVKWSLLELSKA | 836 | Q9P225 | |
| EHIKWKGLLLTALLL | 11 | Q9UQ72 | |
| AAAKKVWSARRLLVL | 6 | Q8WWT9 | |
| TCLLLWVKQRKDLLH | 71 | H0Y7S4 | |
| LKQSLSLMRDLLLHW | 246 | Q96AC6 | |
| QRIKWKGLLLTASLL | 11 | P11464 | |
| ADELLFRQIAWIKKL | 291 | Q15406 | |
| LKRTWEKLLLAARAI | 51 | P08865 | |
| WKNTLALAAILVLLR | 1086 | A6NKG5 | |
| NLTWKIKLRSAVYLS | 161 | P59538 | |
| WLIQKLSRIAKLEAA | 2621 | O75691 | |
| NLLRLLNKLTKWKHS | 666 | Q9ULQ0 | |
| LKKRILNFLTESGWI | 401 | Q86TJ2 | |
| LSVVGTALLLWNKKR | 176 | Q8NET5 | |
| LLRILNKLTKWKHSR | 671 | Q5VSL9 | |
| KISDWALKLSSLDRR | 951 | Q149N8 | |
| ELSKTLGKLWRLLSE | 131 | P57073 | |
| SKTLGKLWRLLNESE | 136 | P48436 | |
| LLLSIKWNKLEDVAQ | 576 | P42338 | |
| LLHKWSLIERDLKLQ | 1981 | O60287 | |
| LLSTKEALLVWCQRK | 176 | Q9NRC6 | |
| WANLEQLSAIRKKRL | 726 | Q01082 | |
| VFWILKRKLSSLNSE | 526 | Q9BY15 | |
| WDQRANALKKIRSLL | 106 | O75122 | |
| IKRNLSDLLEKVKWA | 416 | Q7Z4H8 | |
| RVLEKQWTSFLKARL | 276 | Q9H3T3 | |
| PSDQILKLLSLWRIK | 321 | O00300 | |
| LLWKHLKSSLRILFR | 46 | A0A1B0GUW6 | |
| LLALKAKWPDRITLL | 96 | O00743 | |
| NAELSKTLGKLWRLL | 131 | P56693 | |
| WIQASTLKELLDLKA | 236 | P47989 | |
| IALRSLLAIDLWLSK | 101 | Q8IY26 | |
| LLAIDLWLSKKLGVC | 106 | Q8IY26 | |
| DQKKLVSSDLWRIVL | 2416 | Q7Z7G8 | |
| KVLLLLTDLSLLWKF | 766 | Q9Y2L5 | |
| VSLWAKLKLQKASER | 456 | Q12874 | |
| LKSWTVEDLQKRLLA | 436 | Q13043 | |
| STLFSLKLKWLALVV | 141 | A6NH52 | |
| LKLKWLALVVAGISL | 146 | A6NH52 | |
| KALKSRISWEGLLAL | 711 | Q9BXT5 | |
| IKKNDSLLLAWNKAL | 591 | O15050 | |
| DKWRDLNVISSLLKS | 1211 | Q5T5U3 | |
| AKDSRLGLNSKWLSL | 16 | Q52LC2 | |
| IISKWKSLLENDQLL | 451 | Q9UBB9 | |
| TKLSLLLDNERWKQA | 681 | Q9P1Q0 | |
| ELIARNTWTLKKLPL | 251 | P16473 | |
| KSAVRWLLELSKKNI | 1291 | P35573 | |
| RWKRLRLLLTIQKGS | 4986 | O14686 | |
| LASKLQLDLSVVKIW | 41 | A8MZ59 | |
| LRKLTVLKLWHNSIT | 636 | Q8TDW0 | |
| WFHSLKLSLKNRILN | 681 | Q496Y0 |